The test screens blood samples for molecular traces indicating the presence of precancerous polyps. The test is designed to complement colonoscopy.
Initial results are promising, but the test is still in the research phase. It has the potential to become a first-line screening test to identify patients with warning signs of colorectal cancer.
More articles on gastroenterology:
4 GI physicians in the news – Aug. 21, 2015
Exact Sciences’ price target hits $29
AGA proposes alternative to MOC recertification
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
